WO2003064400A1 - Procede permettant la production d'un compose 1,2,3-triazole - Google Patents
Procede permettant la production d'un compose 1,2,3-triazole Download PDFInfo
- Publication number
- WO2003064400A1 WO2003064400A1 PCT/JP2003/001062 JP0301062W WO03064400A1 WO 2003064400 A1 WO2003064400 A1 WO 2003064400A1 JP 0301062 W JP0301062 W JP 0301062W WO 03064400 A1 WO03064400 A1 WO 03064400A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- group
- substituent
- reaction
- compound
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Definitions
- the present invention relates to a novel method for producing a 1,2,3-triazole compound useful as a raw material or an intermediate of a medicine.
- 1,2,3-Triazole compounds are useful as pharmaceutical raw materials or intermediates.
- this compound can be used as an intermediate for producing a tricyclic triazolobenzoazepine derivative useful as an antiallergic agent described in WO99 / 167770.
- a general production method a method is known in which an acetylene compound or an olefin compound is reacted with an azide compound to form a 1,2,3-triazolyl ring by a cycloaddition reaction (H.Wamhoff). ; "Comprehensive Heterocyclic Chemistry", Pergamon Press, New York (1984), Vol 5, p705) o
- the cycloaddition reaction between an olefin compound and an azide compound uses a special olefin compound having a leaving group such as a halogen or a hydroxyl group, and aromatizes the compound by an elimination reaction (H.Wamhoff; " Comprehensive Heterocyclic Chemistry “, Pergamon Press, New York (1984), Vol 5, p712).
- a special olefin compound having a leaving group such as a halogen or a hydroxyl group
- an elimination reaction H.Wamhoff; " Comprehensive Heterocyclic Chemistry ", Pergamon Press, New York (1984), Vol 5, p712).
- conversion to a special olefin compound is required, so that the production process becomes longer, and it is necessary to use conditions such as high temperature and high pressure for the elimination reaction during aromatization. Can be disadvantageous in some respects.
- Heterocycles vol. 51, p481 (1999) and J. Med. Chem., Vol. 26, p714 (1983) disclose a method of allowing an azide compound to act on an olefin compound having no leaving group. However, it is not an efficient method due to the low yield.
- W 099/1 670 describes the conversion of olefin compounds to acetylene compounds.
- a general conversion method is disclosed.
- this conversion method requires a long manufacturing process and is economically disadvantageous.
- an object of the present invention is to provide an efficient and inexpensive method for producing a 1,2,3-triazole compound.
- the method according to the present invention is a method for producing a 1,2,3-triazole compound represented by the following general formula (I):
- R 1 is an aryl group which may have a substituent, an amino group which may have a substituent, an alkyl group which may have a substituent or an alkoxy group which may have a substituent
- R 2 represents a carboxylic acid protecting group
- R 3 represents an alkali metal, a hydrogen atom, an alkyl group which may have a substituent, an aryl group which may have a substituent, or a substituent Represents an optionally substituted alkylsulfonyl group, an optionally substituted arylsulfonyl group or a trialkylsilyl group.
- ⁇ alkyl '' and ⁇ alkoxy '' as a group or part of a group refer to groups wherein the group is linear, branched or cyclic, having 1 to 6 carbon atoms.
- C means alkyl and alkoxy having preferably 1 to 4 carbon atoms.
- the aryl group means a phenyl group or a naphthyl group.
- the one or more substituents on the aryl group represented by R ′ include the following (a) to (n):
- R 12 and R 13 may be the same or different and each is a hydrogen atom or a group — COR 16 (where R 16 is a hydrogen atom, 6 alkyl Or a phenyl group (this phenyl group may be substituted with a Ci-4 alkyl group or a Ci-6 alkoxy group (the alkoxy group may be substituted with a phenyl group)) ).
- Examples of one or more substituents of the amino group represented by R 1 include an alkyl group, an aryl group, an acyl group (preferably an alkylcarbonyl group), and a sulfonyl group which may have a substituent.
- Examples of the group include an alkyl group which may be substituted with a phenyl group).
- a linear alkyl group for example, a methyl group, an ethyl group, an n-propyl group, an n-butyl group, an n-pentyl group, an n-hexyl group
- branched-chain alkyl groups e.g., isopropyl group, isobutanol butyl group, te rt - butyl group, 3-pentyl
- cyclic C 3 - 7 alkyl group such as cyclopropyl group, cyclobutyl group, cyclopentyl group, Hexyl group.
- R 1 is phenyl, 3-methoxyphenyl, 4-methoxyphenyl, 3,4-dimethoxyphenyl, 6-amino-3,4-dimethoxyphenyl, 3 , 4-Dimethoxy-phenylamino, ethoxyl and methoxyl groups, more preferably 3,4-dimethoxyphenyl, 3,4-dimethyl Xylphenylamino and methoxyl groups.
- preferred examples of the protecting group for the carboxylic acid represented by R 2 include methyl, ethyl, tert-butyl, benzyl, 4-methoxybenzyl, diphenylmethyl, 4-nitrobenzyl, tert-butyldimethylsilyl And triphenylsilyl, 2-phenylsulfonylethyl, 2-methoxycarbonylethyl, 2-cyanoethyl and 2-trimethylsilylethyl groups, more preferably methyl, ethyl, tert-butyl, benzyl, 4 -Methoxybenzyl, diphenylmethyl, 4-nitrobenzyl, tert-butyldimethylsilyl, triphenylsilyl, 2-phenylsulfonylethyl, 2-methoxycarbonylethyl, 2-cyanoethyl, 2-trimethylsilylethyl Particularly preferably, it is an ethyl group
- the substituent of the alkyl group, alkylsulfonyl group and arylsulfonyl group represented by R 3 may be a phenyl group (this phenyl group may be substituted by a nitro group or an alkoxy group). Good).
- R 3 examples include methyl, ethyl, benzyl, p-nitrobenzyl, P-methoxybenzyl, methylsulfonyl, ethylsulfonyl, benzylsulfonyl, p-nitrobenzylsulfonyl, and p-methoxybenzylsulfonyl Phenyl, p-methoxyphenyl, p-nitrophenyl, naphthyl group, trimethylsilyl, triethylsilyl, tert-butyldimethylsilyl, triphenylsilyl, tert-butyldiphenylsilyl, alkali metal, and hydrogen atom.
- the ratio of the compound is not particularly limited and may be determined as appropriate.
- the azide compound of the general formula (III) is added to the compound of the general formula (II) in an amount of 0.5 to 20 mole equivalent. It is preferably used, more preferably 1 to 3 molar equivalents.
- the reaction is carried out in a suitable solvent at room temperature or by heating.
- the solvent used in the reaction is not particularly limited as long as it does not hinder the progress of the reaction.
- Alkyl alcohols such as methanol, ethanol, isopropanol, butanol, alkyl ethers such as tetrahydrofuran, dioxane, diphenyl ether, methylene chloride, chloroform, 1,1,2,2-tetrachloroethane, etc.
- Halogenated hydrocarbons aromatic hydrocarbons such as benzene, toluene, and xylene; ketones such as acetone and 2-butanone; aprotic compounds such as N, N-dimethylformamide, dimethylsulfoxide, and acetonitrile
- a polar solvent or water can be used alone or as a mixture.
- the reaction temperature is preferably from ⁇ 20 ° C. to the boiling point of the solvent, more preferably from 0 ° C. to the boiling point of the solvent.
- the reaction time is preferably from 10 minutes to 48 hours, more preferably from 2 hours to 15 hours.
- the transition metal compound used in the reaction according to the present invention is preferably copper chloride (I), copper bromide (I), copper iodide (I), iron bromide (111), iron chloride (111), iodide.
- the method of the present invention is preferably used because it is carried out in the presence of an oxidizing agent to give the compound of the general formula (I) in a better yield.
- oxidizing agents include halogenates such as chlorates, chlorites, bromates and iodates, and organic compounds such as persulfates, hydrogen peroxide, peracetic acid, and 4-methyl perbenzoate.
- Metal oxides such as peracid, manganese dioxide and chromic acid are preferred, and more preferred are sodium chlorate and sodium bromate.
- the amount of the oxidizing agent to be used is preferably 0.1 to 5 molar equivalents, more preferably 0.4 to 1.5 equivalents, to the compound of the general formula (II).
- oxygen can also provide the compound of the general formula (I) in a better yield, in which case the reaction is carried out under an oxygen atmosphere or in a reaction solution until the reaction is completed.
- oxygen is ventilated.
- the compound obtained by the production method of the present invention can be easily purified by a usual purification method such as recrystallization, chromatography, distillation and the like after performing a reaction termination treatment as required.
- the aqueous layer was adjusted to pH 1.8 with 2N hydrochloric acid, and extracted with ethyl acetate. After the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The obtained oily substance was dried under reduced pressure to obtain ethyl 5- (3,4-dimethoxybenzoyl) 1,1,2,3-triazole-4-carboxylate (149 mg, 65%) each time.
- reaction temperature was lowered to 5 ° C, and N, N-dimethyl ethyl 4- (3,4-dimethoxyphenol) -4-oxo-2-butenoate (2.50 g, 9.46 mmol) was obtained.
- a chloroform solution (1 OmL) was added, and the mixture was heated to room temperature and stirred for 4 hours.
- the reaction solution was poured into ice water (75 mL), sodium nitrite (636 mg, 9.22 mmol 1) was added, the mixture was adjusted to 111.8 with 6 ⁇ [sulfuric acid, and extracted with ethyl acetate.
- a 5 wt% saline solution was added to the organic layer, and the mixture was adjusted to pH 1.5 with 1N hydrochloric acid, and then subjected to a liquid separation operation.
- the organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. Toluene was added to the residue and evaporated under reduced pressure. The obtained crystals are washed with toluene, dried under reduced pressure, and ethyl 5- (3,4-dimethoxypentyl) —every 1,1,2,3-triazolyl-4-carboxylate (4.71,8) 1%).
- reaction solution was poured into ice water (75 mL), sodium nitrite (1.00 g, 14.5 mmol) was added, and the mixture was adjusted to pH 1.8 with 2N hydrochloric acid.
- a saturated saline solution was added to the organic layer, and the mixture was adjusted to 111.0 with 1 hydrochloric acid.
- the solvent was distilled off under reduced pressure. The resulting oil was dried under reduced pressure to give ethyl 1H-1,2,3-tria. Zol-4,5-dicarboxylate (5.96 g, 96%) was obtained.
- reaction solution was poured into ice water, sodium nitrite (494 mg, 7.16 mmol) was added, and the mixture was adjusted to pH 1.5 with 2N hydrochloric acid.
- sodium nitrite (494 mg, 7.16 mmol) was added, and the mixture was adjusted to pH 1.5 with 2N hydrochloric acid.
- a saturated saline solution was added to the organic layer, and the mixture was adjusted to pH 1.5 with 1N hydrochloric acid, followed by liquid separation. After the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure to about 2 OmL.
- the precipitated solid was collected by filtration, washed with ethyl acetate, dried under reduced pressure, and then dried with ethyl 5- (3,4-dimethoxyphenylcarbamoyl) 1,1,1-triazole-4-carboxylate at a time. (888 mg, 77%).
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE60313124T DE60313124T2 (de) | 2002-02-01 | 2003-02-03 | Verfahren zur herstellung einer 1,2,3-triazolverbindung |
US10/502,392 US7238719B2 (en) | 2002-02-01 | 2003-02-03 | Process for producing 1,2,3-Triazole compounds |
EP03734911A EP1471058B1 (en) | 2002-02-01 | 2003-02-03 | Process for producing 1,2,3-triazole compound |
JP2003564023A JP4434747B2 (ja) | 2002-02-01 | 2003-02-03 | 1,2,3−トリアゾール化合物の製造法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-24900 | 2002-02-01 | ||
JP2002024900 | 2002-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2003064400A1 true WO2003064400A1 (fr) | 2003-08-07 |
Family
ID=27654505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/001062 WO2003064400A1 (fr) | 2002-02-01 | 2003-02-03 | Procede permettant la production d'un compose 1,2,3-triazole |
Country Status (7)
Country | Link |
---|---|
US (1) | US7238719B2 (ja) |
EP (1) | EP1471058B1 (ja) |
JP (1) | JP4434747B2 (ja) |
AT (1) | ATE359277T1 (ja) |
DE (1) | DE60313124T2 (ja) |
ES (1) | ES2283781T3 (ja) |
WO (1) | WO2003064400A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9918964B2 (en) | 2010-04-23 | 2018-03-20 | The Board Of Trustees Of The Leland Stanford Junior University | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7375234B2 (en) * | 2002-05-30 | 2008-05-20 | The Scripps Research Institute | Copper-catalysed ligation of azides and acetylenes |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56127363A (en) * | 1980-03-11 | 1981-10-06 | Agency Of Ind Science & Technol | Preparation of 1,2,3-triazole derivative |
EP0400842A1 (en) * | 1989-05-18 | 1990-12-05 | Schering Agrochemicals Limited | Triazole pesticides |
JP2001233767A (ja) * | 2000-02-25 | 2001-08-28 | Shionogi & Co Ltd | アポai発現亢進剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995018130A1 (fr) * | 1993-12-28 | 1995-07-06 | Meiji Seika Kabushiki Kaisha | Derives tricycliques de benzazepine et benzothiazepine |
KR0176010B1 (ko) | 1994-09-01 | 1999-03-20 | 고바야시 유끼오 | 1-아미노-1,2,3-트리아졸의 제법 |
JP3537446B2 (ja) * | 1995-06-15 | 2004-06-14 | 明治製菓株式会社 | 三環性ベンゾアゼピン化合物 |
DE19636122A1 (de) | 1995-09-08 | 1997-04-10 | Dynamit Nobel Ag | Verfahren zur Herstellung von 1,5-unsubstituierten-1H-1,2,3 Triazol-4-carbonsäurederivaten |
NZ503601A (en) * | 1997-09-29 | 2002-02-01 | Meiji Seika Kaisha | Tricyclic triazolobenzazepine derivatives for use as antiallergic medicaments |
-
2003
- 2003-02-03 ES ES03734911T patent/ES2283781T3/es not_active Expired - Lifetime
- 2003-02-03 AT AT03734911T patent/ATE359277T1/de not_active IP Right Cessation
- 2003-02-03 EP EP03734911A patent/EP1471058B1/en not_active Expired - Lifetime
- 2003-02-03 DE DE60313124T patent/DE60313124T2/de not_active Expired - Lifetime
- 2003-02-03 WO PCT/JP2003/001062 patent/WO2003064400A1/ja active IP Right Grant
- 2003-02-03 US US10/502,392 patent/US7238719B2/en not_active Expired - Fee Related
- 2003-02-03 JP JP2003564023A patent/JP4434747B2/ja not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56127363A (en) * | 1980-03-11 | 1981-10-06 | Agency Of Ind Science & Technol | Preparation of 1,2,3-triazole derivative |
EP0400842A1 (en) * | 1989-05-18 | 1990-12-05 | Schering Agrochemicals Limited | Triazole pesticides |
JP2001233767A (ja) * | 2000-02-25 | 2001-08-28 | Shionogi & Co Ltd | アポai発現亢進剤 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9918964B2 (en) | 2010-04-23 | 2018-03-20 | The Board Of Trustees Of The Leland Stanford Junior University | Reducing platelet activation, aggregation and platelet-stimulated thrombosis or blood coagulation by reducing mitochondrial respiration |
Also Published As
Publication number | Publication date |
---|---|
ES2283781T3 (es) | 2007-11-01 |
DE60313124T2 (de) | 2007-08-23 |
DE60313124D1 (de) | 2007-05-24 |
EP1471058A1 (en) | 2004-10-27 |
US20050080270A1 (en) | 2005-04-14 |
ATE359277T1 (de) | 2007-05-15 |
JP4434747B2 (ja) | 2010-03-17 |
US7238719B2 (en) | 2007-07-03 |
EP1471058B1 (en) | 2007-04-11 |
JPWO2003064400A1 (ja) | 2005-05-26 |
EP1471058A4 (en) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5702392B2 (ja) | キサンチンオキシダーゼ阻害剤として効果的な新規化合物、その製造方法及びそれを含有する医薬組成物 | |
JP4549534B2 (ja) | 複素環を有するインドール誘導体及びモノ又はジアザインドール誘導体 | |
JP2002105055A (ja) | イリジウム錯体またはその互変異性体の製造方法 | |
HU227492B1 (en) | Intermediates for the preparation of agents having antifungal activity, processes for the preparation thereof | |
WO2006104088A1 (ja) | 1-(3-(2-(1-ベンゾチオフェン-5-イル)エトキシ)プロピル)アゼチジン-3-オールまたはその塩の製造法 | |
JPS59108781A (ja) | イミダゾリルアルキルチエニル−テトラヒドロピリダジン類およびその製法 | |
BG60539B2 (bg) | Антибактериални средства | |
JP2753659B2 (ja) | ピラゾール誘導体 | |
JPS60260585A (ja) | 抗菌剤の製法 | |
WO2005009991A1 (ja) | 1,2,4−トリアゾール化合物の製造方法及びその中間体 | |
JP6436204B2 (ja) | ピリダジノン化合物の製造方法およびその製造中間体 | |
JPH0314566A (ja) | ベンズイミダゾール誘導体 | |
JP4434747B2 (ja) | 1,2,3−トリアゾール化合物の製造法 | |
EP1534705B1 (en) | Process for preparing zolmitriptan compounds | |
JP2005041802A (ja) | 1,2,4−トリアゾール化合物の製造方法 | |
CN1022836C (zh) | 制备2β-取代-甲基青霉素衍生物的方法 | |
US20220041593A1 (en) | Synthesis for 3-bromo-5-(2-ethylimidazo[1, 2-alpha]pyridine- 3-carbonyl)-2-hydroxybenzonitrile | |
CN109896989B (zh) | 一种5-氧代-2H-芳环并[g]吲哚-1-氧化物的合成方法 | |
JP2896949B2 (ja) | 1−(4−アシルフェニル)アゾール類の製造方法 | |
JPS5920286A (ja) | β−ラクタム抗生物質の新規なカルボン酸エステル類 | |
JP3706154B2 (ja) | 新規なハロメチレン化合物またはその塩 | |
Shafiee et al. | Syntheses of substituted‐1, 2, 4‐triazoles | |
JPH0214348B2 (ja) | ||
JPH01246277A (ja) | ジヒドロベンゾフラン誘導体 | |
JPH02160791A (ja) | セファロスポリン誘導体の製造法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003564023 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10502392 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003734911 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003734911 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2003734911 Country of ref document: EP |